DK1047704T4 - Fremgangsmåde til fremstilling af lithium-, kalium-, calcium- og magnesiumsalte af fludarabin-phosphat og rensningsfremgangsmåde til fremstilling af fludarabin-phosphat og fludarabin-phosphat med en renhed på mindst 99,5% - Google Patents

Fremgangsmåde til fremstilling af lithium-, kalium-, calcium- og magnesiumsalte af fludarabin-phosphat og rensningsfremgangsmåde til fremstilling af fludarabin-phosphat og fludarabin-phosphat med en renhed på mindst 99,5%

Info

Publication number
DK1047704T4
DK1047704T4 DK98965703T DK98965703T DK1047704T4 DK 1047704 T4 DK1047704 T4 DK 1047704T4 DK 98965703 T DK98965703 T DK 98965703T DK 98965703 T DK98965703 T DK 98965703T DK 1047704 T4 DK1047704 T4 DK 1047704T4
Authority
DK
Denmark
Prior art keywords
fludarabine phosphate
purity
lithium
potassium
calcium
Prior art date
Application number
DK98965703T
Other languages
Danish (da)
English (en)
Other versions
DK1047704T3 (da
Inventor
Ulf Tilstam
Klaus Nickisch
Thomas Schmitz
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7852365&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1047704(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Application granted granted Critical
Publication of DK1047704T3 publication Critical patent/DK1047704T3/da
Publication of DK1047704T4 publication Critical patent/DK1047704T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/19—Purine radicals with arabinosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK98965703T 1997-12-11 1998-11-30 Fremgangsmåde til fremstilling af lithium-, kalium-, calcium- og magnesiumsalte af fludarabin-phosphat og rensningsfremgangsmåde til fremstilling af fludarabin-phosphat og fludarabin-phosphat med en renhed på mindst 99,5% DK1047704T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19756289 1997-12-11
PCT/EP1998/007651 WO1999029710A2 (de) 1997-12-11 1998-11-30 Reinigungsverfahren zur herstellung von fludarabin-phosphat

Publications (2)

Publication Number Publication Date
DK1047704T3 DK1047704T3 (da) 2003-06-23
DK1047704T4 true DK1047704T4 (da) 2008-03-25

Family

ID=7852365

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98965703T DK1047704T4 (da) 1997-12-11 1998-11-30 Fremgangsmåde til fremstilling af lithium-, kalium-, calcium- og magnesiumsalte af fludarabin-phosphat og rensningsfremgangsmåde til fremstilling af fludarabin-phosphat og fludarabin-phosphat med en renhed på mindst 99,5%

Country Status (21)

Country Link
US (2) US6046322A (no)
EP (1) EP1047704B2 (no)
JP (2) JP4261051B2 (no)
KR (2) KR20050085937A (no)
AT (2) ATE231880T1 (no)
AU (1) AU739574B2 (no)
CA (1) CA2313486A1 (no)
CZ (1) CZ296366B6 (no)
DE (2) DE59807096D1 (no)
DK (1) DK1047704T4 (no)
ES (1) ES2190136T5 (no)
HK (1) HK1033831A1 (no)
HU (1) HU226997B1 (no)
IL (1) IL136283A (no)
NO (1) NO315324B1 (no)
PL (1) PL195712B1 (no)
SI (1) SI1047704T2 (no)
SK (1) SK283475B6 (no)
TW (1) TW424093B (no)
WO (1) WO1999029710A2 (no)
ZA (1) ZA9811338B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU226997B1 (en) 1997-12-11 2010-04-28 Alcafleu Man Gmbh & Co Kg Method for producing lithium, sodium, potassium, calcium and magnesium salts of fludarabin phosphate purification method for producing fludarabin phosphate and fludarabin phosphate which is at least 99,5% pure
KR100381930B1 (ko) * 2000-03-16 2003-04-26 (주)바이오니아 유전자 변형 농산물 검출방법 및 검출용 프라이머
WO2003049764A1 (en) 2001-12-12 2003-06-19 Fh Faulding & Co Limited Composition for viral preservation
DE10164510A1 (de) * 2001-12-20 2003-07-10 Schering Ag Orale Fludara reinst Formulierung mit schneller Freisetzung des Wirkstoffes
EP1542531A4 (en) * 2002-05-24 2011-01-05 Sicor Inc Aqueous fludarabine phosphorus composition
EP1464708A1 (en) * 2003-04-03 2004-10-06 Pro. Bio. Sint. S.p.A. A process for the preparation of fludarabine phosphate from 2-fluoroadenine
US7698201B2 (en) * 2006-09-14 2010-04-13 The Prudential Insurance Company Of America Financial instrument utilizing an optional benefit election
CN103040855B (zh) * 2012-12-28 2014-05-14 海南锦瑞制药股份有限公司 一种磷酸氟达拉滨的药物组合物及其制备方法
EP3342778B1 (en) * 2015-08-28 2022-01-12 Zhejiang Hisun Pharmaceutical Co., Ltd. Crystal form of fludarabine phosphat, preparation method therefor, and application thereof
CN109265505A (zh) * 2018-09-12 2019-01-25 连云港杰瑞药业有限公司 一种磷酸氟达拉滨异构体杂质的合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE756704A (fr) 1969-09-26 1971-03-01 Parke Davis & Co Procede de production du 5'-phosphate de 9-(beta-d- arabinofuranosyl) adenine et de ses sels
US4188378A (en) * 1978-01-04 1980-02-12 The United States Of America As Represented By The Department Of Health, Education And Welfare Anticancer and antiviral activity of 9-β-D-arabinofuranosyl-2-fluoroadenine
US4210745A (en) * 1978-01-04 1980-07-01 The United States Of America As Represented By The Department Of Health, Education And Welfare Procedure for the preparation of 9-β-D-arabinofuranosyl-2-fluoroadenine
US4357324A (en) * 1981-02-24 1982-11-02 The United States Of America As Represented By The Department Of Health And Human Services Prodrug derivatives of 9β-D-arabinofuranosyl-2-fluoroadenine
DE3323621A1 (de) 1982-07-08 1984-03-01 Yamasa Shoyu K.K., Choshi, Chiba Pharmazeutisches praeparat mit die antitumor-wirkung verstaerkender wirkung, ein solches praeparat enthaltende chemotherapeutische zusammensetzung und verwendung des praeparates zur unterstuetzung der antitumor-behandlung beim menschen und tier
US5110919A (en) * 1989-12-04 1992-05-05 Ash Stevens, Inc. Process for the preparation of 2-amino-9-(2,3,5-tri-o-benzyl-beta-d-arabinofuranosyl) adenine and novel intermediates
EP0487719B1 (en) * 1990-06-27 1998-08-12 Ash Stevens, Inc. Process for the preparation of 9-beta-d-arabinofuranosyl-2-fluoroadenine 5'-phosphate
US5602246A (en) 1992-11-25 1997-02-11 Schering Aktiengesellschaft Process for the preparation of fludarabine or fludarabine phosphate from guanosine
FR2701027B1 (fr) * 1993-02-01 1997-07-18 Warner Lambert Co Procede de synthese ameliore du 9-(beta-d-arabinofuranosyl)adenine 5'-phosphate.
DE19543052A1 (de) * 1995-11-06 1997-05-07 Schering Ag Verfahren zur Herstellung und Reinigung von Fludarabin-Phosphat und die Verwendung von sauren Ionenaustauschern im Verfahren
IT1276126B1 (it) 1995-11-14 1997-10-27 Archimica Spa Procedimento per la preparazine di 9-((2-idrossietossi)metil) guanina
HU226997B1 (en) 1997-12-11 2010-04-28 Alcafleu Man Gmbh & Co Kg Method for producing lithium, sodium, potassium, calcium and magnesium salts of fludarabin phosphate purification method for producing fludarabin phosphate and fludarabin phosphate which is at least 99,5% pure
US6174873B1 (en) 1998-11-04 2001-01-16 Supergen, Inc. Oral administration of adenosine analogs

Also Published As

Publication number Publication date
HUP0100169A3 (en) 2002-04-29
KR100532898B1 (ko) 2005-12-05
SI1047704T2 (sl) 2008-02-29
PL341659A1 (en) 2001-04-23
ATE231880T1 (de) 2003-02-15
CA2313486A1 (en) 1999-06-17
JP4261051B2 (ja) 2009-04-30
CZ20002159A3 (cs) 2000-09-13
DE29825173U1 (de) 2005-12-22
CZ296366B6 (cs) 2006-02-15
SI1047704T1 (en) 2004-02-29
US7547776B1 (en) 2009-06-16
IL136283A (en) 2006-10-31
WO1999029710A2 (de) 1999-06-17
SK8872000A3 (en) 2001-03-12
ES2190136T3 (es) 2003-07-16
AT8617U1 (de) 2006-10-15
US6046322A (en) 2000-04-04
JP2009040797A (ja) 2009-02-26
EP1047704B2 (de) 2007-11-07
AU2155099A (en) 1999-06-28
WO1999029710A3 (de) 1999-09-10
HUP0100169A1 (hu) 2001-11-28
HK1033831A1 (en) 2001-09-28
ES2190136T5 (es) 2008-03-01
EP1047704B1 (de) 2003-01-29
KR20010032919A (ko) 2001-04-25
EP1047704A2 (de) 2000-11-02
IL136283A0 (en) 2001-05-20
HU226997B1 (en) 2010-04-28
DK1047704T3 (da) 2003-06-23
AU739574B2 (en) 2001-10-18
NO20002962L (no) 2000-06-09
TW424093B (en) 2001-03-01
NO20002962D0 (no) 2000-06-09
NO315324B1 (no) 2003-08-18
ZA9811338B (en) 1999-06-10
KR20050085937A (ko) 2005-08-29
PL195712B1 (pl) 2007-10-31
DE59807096D1 (de) 2003-03-06
SK283475B6 (sk) 2003-08-05
JP2001525418A (ja) 2001-12-11

Similar Documents

Publication Publication Date Title
DK1047704T4 (da) Fremgangsmåde til fremstilling af lithium-, kalium-, calcium- og magnesiumsalte af fludarabin-phosphat og rensningsfremgangsmåde til fremstilling af fludarabin-phosphat og fludarabin-phosphat med en renhed på mindst 99,5%
BR9607389A (pt) Purificação de corrente de subproduto na preparação de poliésteres baseados em 1,3 propanediol
ATE236899T1 (de) Neue kristallinische form des kaliumsalzes des (s)-omeprazols
NO20005121D0 (no) FremgangsmÕte for fremstilling av kaliumsulfat
NO20013941L (no) Polynukleotider med forkortet kjede og fremgangsmåte ved fremstillingen derav
BR9407743A (pt) Composiçao oral de peróxido de cálcio-bicarbonato
DK0737169T3 (da) Sammensætning til behandling af vand og rensning af jord
DE69505361D1 (de) Verfahren zur herstellung von kautabletten aus troxerutin, kalziumcarbonat kalziumphosphat, argininaspartat, argininglutamat, amoxicillin, eine kombination aus kalziumcarbonat und magnesiumcarbonat und eine kombination aus aluminiumhydroxyd und magnesiumhydroxyd
GB9908550D0 (en) Process for the purification of brines
ITMI913465A1 (it) Procedimento per la depurazione dell'1, 1, 1-trifluoro-2-fluoroetano
JP2001521062A5 (no)
ZA964427B (en) Alkalinizing potassium salt controlled release preparation.
DK0750616T3 (da) Syreadditionssalte af 2,3,4,5-tetrahydro-1H-3-benzazapinforbindelser
DK0840724T3 (da) Fremgangsmåde til fremstilling af enantiomerisk ren azetidin-2-caboxylsyre
DK0861258T3 (da) Fremgangsmåde til fremstilling af magnesiumpyridoxal-5'-phosphatglutamat og mellemprodukter opnået derved
DK1003903T3 (da) Fremgangsmåde til fremstilling af enantiomerisk berigede N-derivatiserede lactamer
MY118015A (en) Method of crystallizing a tetrahydropyridine derivative and crystalline forms thereby obtained
FI973836A0 (fi) Enfasig gipsbaeddsprocess foer produktion av kaliumsalter
DK0717046T3 (da) Fremgangsmåde til fremstilling af phosphonsyrederivater
BR9809286A (pt) Processos para redução de fibrinogênio
ES512344A0 (es) "procedimiento para la preparacion continua, en una etapa, de granulados de cloruro de magnesio".
DK0441760T3 (da) Fremgangsmåde til rensning af N,N-dimethylmandelsyreamid
ZA977515B (en) Aggregate crystals of phosphoric acid/lysine/magnesium composite salt and process for producing the same.
GB2308432B (en) Improvements relating to flue blocks
NO943008D0 (no) Renseblanding for gallegangen, samt fremgangsmåte for rensing av gallegangen